Manager TitleAgeSince
Chief Executive Officer 62 19/10/2022
President 61 29/03/2021
Comptroller/Controller/Auditor 65 12/08/2024
Director TitleAgeSince
Director/Board Member 62 -
Director/Board Member 63 29/03/2023
Director/Board Member 61 -
Change 5-day change 1-year change 3-year change Capi.($)
+61.97%+49.35% - - 4L
+2.06%+3.33%+21.48%-19.31% 6.31TCr
+0.74%+3.73%+53.05%+208.91% 5.56TCr
-3.10%+34.30%+34.30%+34.30% 4.16TCr
-2.36%+6.28%-51.83%-59.27% 3.9TCr
+6.97%+8.17%+70.21%-23.28% 2.98TCr
+12.59%+13.35%+144.26%-44.13% 2.37TCr
+5.78%+9.73%+60.64%+80.73% 2.15TCr
-1.25%-1.31%-8.80%+146.80% 1.69TCr
-0.81%+5.91%+68.18%+121.16% 1.67TCr
Average +8.21%+3.29%+43.50%+49.55% 3.42TCr
Weighted average by Cap. +1.76%+3.29%+37.42%+45.51%
Logo SL Therapeutics, Inc.
SL Therapeutics Inc, formerly Stem Lab Inc, is a Korea-based company principally engaged in the manufacture and sale of biopharmaceuticals. The Company is principally engaged in the development, research, manufacture and sale of biopharmaceuticals such as stem cell culture mediums, stem cell treatment as well as others.
Employees
-
  1. Stock Market
  2. Stocks
  3. A258540 Stock